Skip to content
Aspivix logo
  • News
  • About us
  • Contact
  • English
    • Français
    • Italiano
    • Deutsch
Buy Now
Search
Close
  • For Healthcare Professionals
  • For Women
  • Find your OBGYN
  • Resources
  • News
  • About us
  • Contact
  • English
    • Français
    • Italiano
    • Deutsch
Buy Now
  • For Healthcare Professionals
  • For Women
  • Find your OBGYN
  • Resources
Aspivix logo
Home > News

Press Contact
For media enquiries, please reach out to: contact@aspivix.com

All
  • All
  • Blog
  • In the media
  • Press releases
75

Innovation in women’s health comes in small doses

December 30, 2020
Read More about Innovation in women’s health comes in small doses
76

5 Top Emerging Reproductive Health Startups

December 30, 2020
Read More about 5 Top Emerging Reproductive Health Startups
77

Les premières données cliniques tombent pour Aspivix, et elles sont réjouissantes !

December 17, 2020
Read More about Les premières données cliniques tombent pour Aspivix, et elles sont réjouissantes !
78

ASPIVIX’s Press Release featured in Investhirozon.eu

December 14, 2020
Read More about ASPIVIX’s Press Release featured in Investhirozon.eu
50

ASPIVIX Reports Positive First-in-Women Results Using Novel Suction-based Cervical Device in IUD Procedures

December 12, 2020
RENENS, Switzerland, Dec. 10, 2020 /PRNewswire/ — ASPIVIX SA, a developer of medical technologies to advance gynecological care, today announced completion of and interim analysis results from its Phase I first-in-women trial. The ADVANCE Women (Atraumatic...
Read More about ASPIVIX Reports Positive First-in-Women Results Using Novel Suction-based Cervical Device in IUD Procedures
79

It’s Time For The Next-Generation Gentle and Modern Gynecology

December 11, 2020
Read More about It’s Time For The Next-Generation Gentle and Modern Gynecology
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
Loading... loader
Scroll to learn more

Company

  • Home
  • Product
  • Resources
  • Careers
  • News

Contact

Global Headquarters
Aspivix SA
Route de la Corniche 8
1066 Epalinges
Switzerland

contact@aspivix.com

Legal

  • Cookie Policy
  • Privacy Statement
  • Imprint
  • Disclaimer

Follow

Carevix® is currently FDA-Cleared for US market, CE-Marked for EU market and authorized in UK and Brazil. Available for commercialization. It has not been licensed or approved for sale in other markets.

© 2025 Aspivix SA. All rights reserved. Aspivix™, and Carevix® are trademarks or registered trademarks of Aspivix SA and/or its subsidiaries.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}